Electronic blood glucose monitoring impacts on provider and patient behavior.

Though some alternate transformations as shown in Supplementary Appendix Exhibit A5 are marginally significant, these are not sustained through the 26-week outcome period. 24 Notably, there does appear to be a statistically significant reduction in the probability of having a A1c test among the “Provider Accountability” reminder group (relative to the no-reminder group), particularly during the initial 14-week period.

also in 26,082 other papers